4//SEC Filing
Viney Joanne L. 4
Accession 0000899243-20-019860
CIK 0001807901other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:32 PM ET
Size
14.4 KB
Accession
0000899243-20-019860
Insider Transaction Report
Form 4
Viney Joanne L.
See Remarks
Transactions
- Conversion
Common Stock
2020-07-21+21,133→ 503,254 total - Conversion
Series B Preferred Stock
2020-07-21−107,768→ 0 total→ Common Stock (21,133 underlying) - Purchase
Common Stock
2020-07-21$18.00/sh+1,200$21,600→ 1,200 total(indirect: By Spouse) - Award
Stock Option (right to buy)
2020-07-17+56,637→ 56,637 totalExercise: $18.00Exp: 2030-07-16→ Common Stock (56,637 underlying) - Award
Stock Option (right to buy)
2020-07-17+58,239→ 58,239 totalExercise: $18.00Exp: 2030-07-16→ Common Stock (58,239 underlying)
Footnotes (4)
- [F1]The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
- [F3]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on May 21, 2021, with the remainder of the shares vesting in equal monthly installments following May 21, 2021 through May 21, 2024, subject to the reporting person's continued service on each applicable vesting date.
- [F4]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on June 25, 2021, with the remainder of the shares vesting in equal monthly installments following June 25, 2021 through June 25, 2024, subject to the reporting person's continued service on each applicable vesting date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
Related Parties
1- filerCIK 0001816744
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 7:32 PM ET
- Size
- 14.4 KB